Cargando…

Relapse vs. Re-Infection

Detalles Bibliográficos
Autor principal:	Barton, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F.E. Daniel & S.E. Hudson 1919
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651389/ https://www.ncbi.nlm.nih.gov/pubmed/36957709

Ejemplares similares

Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China
por: Shao, Yan, et al.
Publicado: (2021)

Risk Factors and Outcomes of Recurrent Candidemia in Children: Relapse or Re-Infection?
por: Lai, Mei-Yin, et al.
Publicado: (2019)

Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
por: White, Michael T., et al.
Publicado: (2018)

Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
por: Bryant, Josephine M, et al.
Publicado: (2013)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1
por: Cantrell, W., et al.
Publicado: (2021)

A Simple Scoring System to Differentiate between Relapse and Re-Infection in Patients with Recurrent Melioidosis
por: Limmathurotsakul, Direk, et al.
Publicado: (2008)

Infection prevention in endoscopy practice: comparative evaluation of re-usable vs single-use endoscopic valves
por: Pasquale, L., et al.
Publicado: (2021)

Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2023)

Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2021)

Re-Configuring Identity Postpartum and Sustained Abstinence or Relapse to Tobacco Smoking
por: Brown, Tracey J., et al.
Publicado: (2019)

Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population
por: Coleman, Karen J., et al.
Publicado: (2022)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
por: Gökbuget, N, et al.
Publicado: (2016)

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018)

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment
por: Dimopoulos, M A, et al.
Publicado: (2017)

Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome
por: Bittencourt, Cassiana E., et al.
Publicado: (2015)

Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER(®), RE-COVER™ II, and RE-MEDY™
por: Feuring, Martin, et al.
Publicado: (2017)

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
por: Kappos, Ludwig, et al.
Publicado: (2020)

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
por: Yahav, Dafna, et al.
Publicado: (2021)

Bluetongue Virus Infection of Goats: Re-Emerged European Serotype 8 vs. Two Atypical Serotypes
por: Ries, Christina, et al.
Publicado: (2022)

Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis
por: Dastagir, Akram, et al.
Publicado: (2018)

Edwardsiella tarda Infection Triggering Acute Relapse in Pediatric Crohn's Disease
por: Li, A. K., et al.
Publicado: (2019)

Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016)

Quality of life after refractive surgery: ReLEx SMILE vs Femto-LASIK
por: Klokova, Olga Aleksandrovna, et al.
Publicado: (2019)

p53 vs. ISG15: Stop, you’re killing me
por: Menendez, Daniel, et al.
Publicado: (2014)

(RE) currences in COVID-19: (RE)-activation or (RE)-infection?
por: Shah, Anuradha K., et al.
Publicado: (2021)

Correction: Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome
por: Bittencourt, Cassiana E., et al.
Publicado: (2015)

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
por: Herd, Fiona, et al.
Publicado: (2019)

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
por: Strati, Paolo, et al.
Publicado: (2023)

Potential Prognostic Markers for Relapsed/Refractory vs. Responsive Acute Myeloid Leukemia
por: Vitkevičienė, Aida, et al.
Publicado: (2022)

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR
por: Chng, W-J, et al.
Publicado: (2017)

Comment on 'Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia'
por: Tong, W H
Publicado: (2016)

Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy
por: Lazzaro, Carlo, et al.
Publicado: (2022)

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
por: Yung, W K A, et al.
Publicado: (2000)

Louse-Borne Relapsing Fever (Borrelia recurrentis) in a Somali Refugee Arriving in Italy: A Re-emerging Infection in Europe?
por: Antinori, Spinello, et al.
Publicado: (2016)

Determinants of relapse and re-admission among alcohol abusers after intensive residential treatment
por: Vanderplasschen, WOI, et al.
Publicado: (2010)

How to recognize and respond to viral re-positivity and disease relapse in patients with COVID-19
por: Zheng, Shiliang, et al.
Publicado: (2021)

LIAISON(®) Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study
por: Fiorino, Gionata, et al.
Publicado: (2022)

1659 Relapse vs Reinfection. Evaluation of Clostridium difficile Isolates from Incident and Recurrent Infections, Minnesota 2009-2011
por: Whitten, Tory, et al.
Publicado: (2014)

Using Diverse Communication Strategies to Re-Engage Relapsed Tobacco Quitline Users in Treatment, New York State, 2014
por: Carlini, Beatriz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vkd5p5h11005h32ih4ecfr54g8